Attached files
file | filename |
---|---|
10-Q - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v203151_10q.htm |
EX-31.1 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v203151_ex31-1.htm |
EX-31.2 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v203151_ex31-2.htm |
EX-32.2 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v203151_ex32-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of First China Pharmaceutical Group, Inc.
(the “Company”) on Form 10-Q for the quarterly period ended September 30, 2010,
as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Zhen Jiang Wang, Chief Executive Officer of the Company, certify,
to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
i.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d));
and
|
|
ii.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date: November
17, 2010
/s/ Zhen Jiang Wang
|
Name:
Zhen Jiang Wang
|
Title:
Chief Executive Officer (Principal Executive
Officer)
|